Epigenetics, cholesterol lowering and diabetes: a comparative study of statins and HDAC inhibitors
Embargo Lift Date
MetadataShow full item record
Statins are widely used to lower cholesterol and thus reduce cardiovascular risk, although they increase diabetes risk. Butyrate, which is produced by gut bacteria and alters gene expression through epigenetic means, lowers cholesterol and protects against diabetes in animals. This thesis compares the effects of statins and butyrate on epigenetics, cholesterol metabolism and glucose metabolism in cultured cells. Both statins and butyrate lowered cellular cholesterol and impaired insulin secretion, although they acted through different mechanisms.
Showing items related by title, author, creator and subject.
Kurniawan, Dede Indra (2007)Background. Muscle cramps are one of the adverse affects suffered by hypercholesterolemia patients who are treated with statins. Besides reducing cholesterol levels, statins also reduce coenzyme Q10 (CoQ10) blood levels. ...
Pallebage-Gamarallage, Menuka Madhavi Somapala (2012)Alzheimer’s disease (AD) is the most common cause of dementia pathologically characterised by neurovascular inflammation, extracellular proteinaceous deposits enriched in amyloid-β (Aβ) and formation of neurofibrillar ...
Ko, H.; Lareu, Ricky R.; Dix, B.; Hughes, J. (2017)© 2017 Ko et al. Introduction. The repurposing of non-antibiotic drugs as adjuvant antibiotics may help break antimicrobial resistance (AMR). Statins are commonly prescribed worldwide to lower cholesterol. They also possess ...